MRSA therapeutics market to reach $1.8bn across 7MM in 2034
The MRSA therapeutics market is forecast to grow from $1.3bn in 2024 to $1.8bn in 2034 at a compound annual growth rate (CAGR) of 3.4%.
Comment & Opinion
Can CNS trial momentum convert into late-stage evidence?
Narcolepsy market expected to reach $7.8bn across 7MM by 2035
ESC 2026: oral semaglutide shows lower 3-year CV risk than injectable in T2D
ESC 2026: Head-to-head study compares inclisiran and bempedoic acid
ESC 2026: enlicitide extends oral PCSK9 benefits beyond LDL-C lowering
ESC 2026: laroprovstat evaluated to close the LDL-C treatment gap
Surveillance and vaccine could protect against higher cancer risk from Lynch syndrome
